SCHEMBL6287959

SCHEMBL6287959

Cc1cccc2[nH]cc(CC(=O)O)c12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
KDM4E B2RXH2 3/20 0.69
GAA P10253 2/20 0.69
MEN1 O00255 2/20 0.69
MAPT P10636 2/20 0.69
KMT2A Q03164 2/20 0.69
POLB P06746 1/20 0.69
THRB P10828 1/20 0.69
DNMT1 P26358 1/20 0.69
RECQL P46063 1/20 0.69
CASP6 P55212 1/20 0.69
MCL1 Q07820 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
GPR84 Q9NQS5 1/20 0.65
NPSR1 Q6W5P4 2/20 0.51
TSHR P16473 2/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.45
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31036403 0.84 GPR84 (0.61) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL25139818 0.84 GPR84 (0.61) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL15142475 0.84 GPR84 (0.61) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL25139861 0.84 GPR84 (0.61) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL29441750 0.82 ALDH1A1 (1.00) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL7358453 0.82 ALDH1A1 (1.00) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL29441752 0.82 ALDH1A1 (1.00) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL5066497 0.82 ALDH1A1 (0.71) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL10344754 0.82 GPR84 (0.58) ALDH1A1KDM4EGAAMEN1MAPT
SCHEMBL8297899 0.81 GPR84 (0.76) ALDH1A1KDM4EGAAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245629-A1 MIXTURES AND COMPOSITIONS OF FLUENSULFONE AND AUXIN, AND USES THEREOF ADAMA MAKHTESHIM LTD> (IL) 2020-12-10 WO claimed
EP-2688404-A1 AUXIN PLANT GROWTH REGULATORS The Governors Of The University Of Alberta (CA) 2014-01-29 EP claimed
WO-2012126094-A1 AUXIN PLANT GROWTH REGULATORS GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2012-09-27 WO claimed
US-20230012449-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. 2023-01-12 US disclosed
US-11034668-B2 Compounds for the treatment of HIV GILEAD SCIENCES, INC. (US) 2021-06-15 US disclosed
WO-2020245629-A1 MIXTURES AND COMPOSITIONS OF FLUENSULFONE AND AUXIN, AND USES THEREOF ADAMA MAKHTESHIM LTD> (IL) 2020-12-10 WO disclosed
WO-2020193867-A1 POLYNUCLEOTIDE AND USES THEREOF HELSINGIN YLIOPISTO (FI) 2020-10-01 WO disclosed
US-10370358-B2 Compounds for the treatment of HIV GILEAD SCIENCES, INC. (US) 2019-08-06 US disclosed
US-20180194746-A1 Compounds For the Treatment of HIV GILEAD SCIENCES, INC. 2018-07-12 US disclosed
US-9944619-B2 Compounds for the treatment of HIV GILEAD SCIENCES, INC. (US) 2018-04-17 US disclosed
US-20170137405-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. 2017-05-18 US disclosed
US-20140142085-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. (US) 2014-05-22 US disclosed
EP-2729448-A1 COMPOUNDS FOR THE TREATMENT OF HIV Gilead Sciences, Inc. (US) 2014-05-14 EP disclosed
EP-2688404-A1 AUXIN PLANT GROWTH REGULATORS The Governors Of The University Of Alberta (CA) 2014-01-29 EP disclosed
CN-103347874-A Dimeric iap inhibitors NOVARTIS AG 2013-10-09 CN disclosed
WO-2013006738-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. (US) 2013-01-10 WO disclosed
WO-2012126094-A1 AUXIN PLANT GROWTH REGULATORS GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2012-09-27 WO disclosed
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370358-B2 Compounds for the treatment of HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885
US-20180194746-A1 Compounds For the Treatment of HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK ALDH1A1 2042/4885KDM4E 2972/4885GAA 4704/4885
US-11034668-B2 Compounds for the treatment of HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885
US-20170137405-A1 COMPOUNDS FOR THE TREATMENT OF HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885
US-20140142085-A1 COMPOUNDS FOR THE TREATMENT OF HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885
US-20230012449-A1 COMPOUNDS FOR THE TREATMENT OF HIV CCR5, NPC1, FURIN ALDH1A1 649/4885KDM4E 1590/4885GAA 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.